Long-Acting GHRH Analog | Growth Hormone & IGF-1 Stimulation
$79.95
Shipping calculated at checkout • Free shipping over $100
2-5MG per vial
24 Hour from Perth
30mcg per kg of bodyweight / up to 16 weeks
Note: BAC Water is required for reconstitution with all research peptides
Orders $100+
Lab Verified
GMP Certified
Disclaimer: This product is intended for laboratory research use only. Not for human consumption.
Global Peptide Sciences supplies CJC 1295 DAC in Australia, a long-acting growth hormone-releasing hormone (GHRH) analogue designed for laboratory research. Also referred to as CJC-1295 DAC, this peptide is studied for its extended activity profile and its influence on growth hormone and IGF-1 signalling pathways.
If you’re looking to buy CJC 1295 DAC peptides, our lab-grade product is third-party tested and supplied with full documentation for research use only.
CJC-1295 with DAC (Drug Affinity Complex) is a synthetic analogue of growth hormone-releasing hormone (GHRH). In laboratory research, it is studied for its ability to stimulate growth hormone signalling pathways through activation of the GHRH receptor in the anterior pituitary.
The addition of the Drug Affinity Complex significantly extends the peptide’s half-life by allowing binding to circulating albumin, resulting in prolonged activity compared with shorter-acting GHRH analogues.
CJC-1295 DAC has been investigated in laboratory and clinical research involving:
Studies have demonstrated that administration of CJC-1295 may increase circulating growth hormone and IGF-1 levels for extended periods following a single dose.
Researchers studying long-acting GHRH analogues often select CJC 1295 DAC due to:
This makes CJC-1295 DAC a preferred option in long-duration peptide research models.
If you are searching for CJC 1295 DAC for sale in Australia, Global Peptide Sciences provides lab-grade peptides with COA verification and third-party purity testing.
You can buy CJC 1295 with DAC securely through our online platform. As part of our injectable research peptide range, all products are supplied as peptides with COA, ensuring transparency and research integrity.
This compound is supplied strictly for laboratory research purposes. It is not approved for human consumption or therapeutic use.
CJC-1295 DAC is studied for:
Researchers explore:
Dosage: 30mcg per kg of bodyweight (Example: 90kg × 30mcg = 2700mcg) for up to 16 weeks
Administered subcutaneously once or twice every 5 days.
For optimal alignment, administer in the evening to coincide with natural GH cycles.
Complete your research with these premium peptides
